House passes final opioid package 

Sep 28, 2018 - 03:01 PM
opioids

The House of Representatives today passed by a vote of 393-8 the final version of the Opioid Crisis Response Act (H.R. 6). The House-Senate agreement includes an AHA-supported provision that would allow states to receive federal Medicaid matching funds for up to 30 days per year for services provided to adults aged 21-64 for substance use disorders in Institutions for Mental Diseases. The bill also includes AHA-supported provisions addressing health insurance for former foster youth; maternal and infant health; access to telehealth and medication-assisted treatment; parity in Children’s Health Insurance Program mental health and substance use disorder benefits; a demonstration program to promote alternatives to opioids in emergency departments; revisions to the Hospital Consumer Assessment of Healthcare Providers and Systems questions relating to pain management; care coordination for drug overdose patients; and improvements to coordination of prescription drug monitoring programs. The Senate is expected to vote on the agreement in October.
 

Related News Articles

Headline
Study finds AI screening for OUD led to fewer hospital readmissions 
The National Institutes of Health April 3 released a study that found an artificial intelligence screening tool was as effective as health care providers in…
Headline
Senators reintroduce bipartisan bill expanding telehealth services
A bipartisan group of 60 senators April 2 reintroduced the CONNECT for Health Act, AHA-supported legislation that would expand patient access to telehealth…
Headline
HHS extends public health emergency for opioid crisis
The Department of Health and Human Services March 18 announced that it renewed the public health emergency for the nation’s opioid crisis an additional 90 days…
Headline
OIG report finds just 40% of Medicare enrollees who started treatment for opioid use disorder continued
The Department of Health and Human Services Office of Inspector General Feb. 18 released a report that found about 40% of Medicare enrollees who began opioid…
Headline
DEA and HHS delay implementation of buprenorphine final rule
Today the Drug Enforcement Administration and Department of Health and Human Services announced that the effective date for the final rule regarding…
Headline
FDA approves first-in-class non-opioid painkiller 
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to…